Transcatheter aortic valve implantation (TAVR) has emerged as an alternative, rapidly
evolving treatment option for patients with severe aortic stenosis and high surgical risk …

During this coronavirus disease 2019 (COVID-19) pandemic, there is an international call to
postpone all elective surgeries. Cardiac surgery carries a combined risk for cardiac patients …

Objectives The aim of this study was to examine the value of frailty to predict in-hospital
major bleeding and determine its impact on mid-term mortality following transcatheter …

Data regarding the clinical outcomes of transcatheter aortic valve replacement (TAVR) vs.
surgical aortic valve replacement (SAVR) in cardiac amyloidosis are lacking. Our study …

Background The aim of this study was to identify patients vulnerable for anxiety and/or
depression following aortic valve replacement (AVR) and to evaluate factors that may …

Racial disparities in transcatheter aortic valve replacement (TAVR) implantation results from
several factors, including socioeconomic disparities, inherent biases in healthcare provision …

Objective The durability of bioprosthetic heart valve (BHV) devices, commonly made of
bovine (BP) and porcine (PP) pericardium tissue, is partly limited by device calcification and …

Background Currently, two effective therapeutic options for severe aortic stenosis (AS) are
available, one catheter-based [transcatheter aortic valve implantation (TAVI)], the other open …

Background To determine whether transcatheter aortic valve implantation (TAVI) improves
early (30-day) and midterm (1-year) mortality compared with surgical aortic valve …

We aimed to compare the outcomes of transcatheter aortic valve implantation (TAVI) with
surgical aortic valve replacement (SAVR) in an elderly but nonfrail, minimally co-morbid …